10 Biggest Price Target Changes For Tuesday
Morgan Stanley raised the price target on Microsoft Corporation (NASDAQ: MSFT) from $305 to $331. Microsoft shares rose 0.1% to $297.03 in pre-market trading.
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen’s Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 13)
Oppenheimer Maintains Outperform on aTyr Pharma, Raises Price Target to $20
Oppenheimer analyst Hartaj Singh maintains aTyr Pharma (NASDAQ:LIFE) with a Outperform and raises the price target from $14 to $20.
20 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
Communications Systems, Inc. (NASDAQ: JCS) rose 34.8% to $9.15 in pre-market trading as the company declared a special dividend of $3.50 per share.
Why Did Wainwright Beef Up ATyr Pharma’s Price Target?
H.C. Wainwright increased the price target on ATyr Pharma (NASDAQ:LIFE) to $18 from $13, with the Buy rating unchanged, implying more than…
Mid-Afternoon Market Update: Dow Rises Over 100 Points; Itamar Medical Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 0.38% to 34,739.18 while the NASDAQ fell 0.27% to 15,074.10. The S&P also fell, dropping 0.07% to 4,455.53.
Mid-Day Market Update: Crude Oil Up 1%; MiMedx Group Shares Plummet
Midway through trading Monday, the Dow traded up 0.80% to 34,885.46 while the NASDAQ fell 0.10% to 15,100.02. The S&P also rose, gaining 0.23% to 4,468.75.